In vitro studies show that inflammatory mediators produced by amyloid precursor protein (APP) and β-amyloid protein (Aβ) induce microglial activation and secretion of miR-21 exosomes, affecting AD progression (Fernandes et al., 2018). The gene discussed is APP; the disease is Alzheimer disease.